Diethylstilbestrol alters positive and negative selection of T cells in the thymus and modulates T-cell repertoire in the periphery

Toxicology and Applied Pharmacology

Volumn 212, Issue 2, 2006, Pages 119-126

  Brown, Nicole ^a   Nagarkatti, Mitzi ^a   Nagarkatti, Prakash S ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Developmental toxicity; Diethylstilbestrol; T cell selection

Indexed keywords

DIETHYLSTILBESTROL; HY ANTIGEN; MITOGENIC AGENT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNOMODULATION; LYMPH NODE CELL; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; RECEPTOR DENSITY; T LYMPHOCYTE; THYMOCYTE; THYMUS ATROPHY; TRANSGENIC MOUSE;

ANIMALS; ATROPHY; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; DIETHYLSTILBESTROL; FEMALE; FLOW CYTOMETRY; GENETIC MARKERS; LYMPH NODES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND;

ANIMALIA; MUS MUSCULUS;

EID: 33645793305     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.07.012     Document Type: Article

References (23)

1. Dave V.P., Allman D., Keefe R., Hardy R.R., and Kappes D.J. HD mice: a novel mouse mutant with a specific defect in the generation of CD4(+) T cells. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 8187-8192
2. Dave V.P., Allman D., Wiest D.L., and Kappes D.J. Limiting TCR expression leads to quantitative but not qualitative changes in thymic selection. J. Immunol. 162 (1999) 5764-5774
3. Do Y., Ryu S., Nagarkatti M., and Nagarkatti P.S. Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo. Toxicol. Sci. 70 (2002) 63-72
4. Falk I., Nerz G., Haidl I., Krotkova A., and Eichmann K. Immature thymocytes that fail to express TCRbeta and/or TCRgamma delta proteins die by apoptotic cell death in the CD44(-)CD25(-) (DN4) subset. Eur. J. Immunol. 31 (2001) 3308-3317
5. Fisher M.T., Nagarkatti M., and Nagarkatti P.S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin enhances negative selection of T cells in the thymus but allows autoreactive T cells to escape deletion and migrate to the periphery. Mol. Pharmacol. 67 (2005) 327-335
6. Ford C.D., Johnson G.H., and Smith W.G. Natural killer cells in in utero diethylstilbesterol-exposed patients. Gynecol. Oncol. 16 (1983) 400-404
7. Giusti R.M., Iwamoto K., and Hatch E.E. Diethylstilbestrol revisited: a review of the long-term health effects. Ann. Intern. Med. 122 (1995) 778-788
8. Holladay S.D., Blaylock B.L., Comment C.E., Heindel J.J., Fox W.M., Korach K.S., and Luster M.I. Selective prothymocyte targeting by prenatal diethylstilbestrol exposure. Cell. Immunol. 152 (1993) 131-142
9. Kisielow P., and Miazek A. Positive selection of T cells: rescue from programmed cell death and differentiation require continual engagement of the T cell receptor. J. Exp. Med. 181 (1995) 1975-1984
10. Kisielow P., and von Boehmer H. Development and selection of T cells: facts and puzzles. Adv. Immunol. 58 (1995) 87-209
11. + thymocytes. Nature 333 (1988) 742-746
12. Lai Z.W., Fiore N.C., Gasiewicz T.A., and Silverstone A.E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diethylstilbestrol affect thymocytes at different stages of development in fetal thymus organ culture. Toxicol. Appl. Pharmacol. 149 (1998) 167-177
13. Lai Z.W., Fiore N.C., Hahn P.J., Gasiewicz T.A., and Silverstone A.E. Differential effects of diethylstilbestrol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocyte differentiation, proliferation, and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture. Toxicol. Appl. Pharmacol. 168 (2000) 15-24
14. Levelt C.N., and Eichmann K. Receptors and signals in early thymic selection. Immunity 3 (1995) 667-672
15. Maile R., Siler C.A., Kerry S.E., Midkiff K.E., Collins E.J., and Frelinger J.A. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo. J. Immunol. 174 (2005) 619-627
16. Mor G., Munoz A., Redlinger Jr. R., Silva I., Song J., Lim C., and Kohen F. The role of the Fas/Fas ligand system in estrogen-induced thymic alteration. Am. J. Reprod. Immunol. 46 (2001) 298-307
17. Noller K.L., Blair P.B., O'Brien P.C., Melton III L.J., Offord J.R., Kaufman R.H., and Colton T. Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol. Fertil. Steril. 49 (1988) 1080-1082
18. Okasha S.A., Ryu S., Do Y., McKallip R.J., Nagarkatti M., and Nagarkatti P.S. Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology 163 (2001) 49-62
19. Sebzda E., Mariathasan S., Ohteki T., Jones R., Bachmann M.F., and Ohashi P.S. Selection of the T cell repertoire. Annu. Rev. Immunol. 17 (1999) 829-874
20. Shortman K., and Wu L. Early T lymphocyte progenitors. Annu. Rev. Immunol. 14 (1996) 29-47
21. Silverstone A.E., Frazier Jr. D.E., Fiore N.C., Soults J.A., and Gasiewicz T.A. Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets. Toxicol. Appl. Pharmacol. 126 (1994) 248-259
22. Teh H.S., Kisielow P., Scott B., Kishi H., Uematsu Y., Bluthmann H., and von Boehmer H. Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature 335 (1988) 229-233
23. Ways S.C., Mortola J.F., Zvaifler N.J., Weiss R.J., and Yen S.S. Alterations in immune responsiveness in women exposed to diethylstilbestrol in utero. Fertil. Steril. 48 (1987) 193-197